首页> 美国卫生研究院文献>Infection and Immunity >Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses.
【2h】

Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses.

机译:稳定的LamB-志贺毒素B亚基杂种的构建:鼠伤寒沙门氏菌aroA菌株中的表达分析和B亚基特异性粘膜和血清抗体应答的刺激。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The complete Shiga toxin B subunit and two N-terminal segments of the B subunit have been inserted into a cell surface exposed loop of the LamB protein, and expression of the hybrid proteins from three different promoter systems, i.e., (i) an in vitro-inducible tac promoter that provides high-level expression, (ii) the iron-regulated aerobactin promoter presumably induced in vivo under the iron-limiting conditions of the intestinal mucosal environment, and (iii) a synthetic, modified beta-lactamase promoter providing moderate level constitutive expression, has been analyzed in Escherichia coli, Salmonella typhimurium, and attenuated antigen carrier strains of S. typhimurium (aroA mutants). The hybrid vaccine strains were used to immunize mice by the oral and intraperitoneal routes. S. typhimurium aroA mutants apparently have a membrane export defect which prevents the transport of LamB and its derivatives across the cytoplasmic membrane. High-level expression of hybrid proteins through use of the tac promoter proved deleterious to the vaccine strains and prevented the production of viable cells at reasonable cell densities. The lower levels of gene expression observed with the beta-lactamase and aerobactin promoters did not have this effect. Immunization of mice with S. typhimurium aroA strains carrying the hybrid genes expressed from these two promoters resulted in significant B subunit-specific mucosal and serum antibody responses. This suggests that such expression systems may be useful when incorporated into candidate antidysentery live oral vaccines for inducing protection against the effect of Shiga toxin in infections caused by Shigella dysenteriae 1 and other Shiga toxin-or Shiga-like toxin-producing pathogens.
机译:完整的志贺毒素B亚基和B亚基的两个N末端区段已插入LamB蛋白的细胞表面暴露环中,并从三种不同的启动子系统表达杂合蛋白,即(i)在体外诱导型tac启动子,可提供高水平表达;(ii)可能是在肠粘膜环境的铁限制条件下在体内诱导了铁调节的航空杆菌素启动子,以及(iii)提供中等水平的合成,修饰的β-内酰胺酶启动子已经在大肠杆菌,鼠伤寒沙门氏菌和鼠伤寒沙门氏菌的减毒抗原载体菌株(aroA突变体)中进行了水平表达的分析。杂种疫苗株用于通过口服和腹膜内途径免疫小鼠。鼠伤寒沙门氏菌aroA突变体显然具有膜输出缺陷,可阻止LamB及其衍生物跨细胞质膜转运。通过使用tac启动子高水平表达杂合蛋白被证明对疫苗株有害,并在合理的细胞密度下阻止了活细胞的产生。用β-内酰胺酶和航空杆菌素启动子观察到的较低水平的基因表达没有这种作用。用携带由这两个启动子表达的杂种基因的鼠伤寒沙门氏菌aroA菌株对小鼠进行免疫,可导致明显的B亚基特异性粘膜和血清抗体反应。这表明,当将这些表达系统掺入候选抗痢疾活性口服疫苗中时,在诱导由痢疾志贺氏菌1和其他志贺氏毒素或类似志贺氏菌的毒素产生的病原体引起的感染中抵抗志贺氏菌毒素的作用时,可能是有用的。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号